NO20043124L - Aminoindanderivater som serotonin -og norepinefrin-opptaksinhibitorer - Google Patents
Aminoindanderivater som serotonin -og norepinefrin-opptaksinhibitorerInfo
- Publication number
- NO20043124L NO20043124L NO20043124A NO20043124A NO20043124L NO 20043124 L NO20043124 L NO 20043124L NO 20043124 A NO20043124 A NO 20043124A NO 20043124 A NO20043124 A NO 20043124A NO 20043124 L NO20043124 L NO 20043124L
- Authority
- NO
- Norway
- Prior art keywords
- serotonin
- uptake inhibitors
- norepinephrine uptake
- aminoindane derivatives
- aminoindane
- Prior art date
Links
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 2
- XJEVHMGJSYVQBQ-UHFFFAOYSA-N 2,3-dihydro-1h-inden-1-amine Chemical class C1=CC=C2C(N)CCC2=C1 XJEVHMGJSYVQBQ-UHFFFAOYSA-N 0.000 title 1
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 title 1
- 229940076279 serotonin Drugs 0.000 title 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34336001P | 2001-12-21 | 2001-12-21 | |
| DKPA200101939 | 2001-12-21 | ||
| PCT/DK2002/000873 WO2003055873A1 (fr) | 2001-12-21 | 2002-12-18 | Derives aminoindane utilises comme inhibiteurs de la capture de la serotonine et de la norepinephrine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043124L true NO20043124L (no) | 2004-07-21 |
Family
ID=26069116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043124A NO20043124L (no) | 2001-12-21 | 2004-07-21 | Aminoindanderivater som serotonin -og norepinefrin-opptaksinhibitorer |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7351734B2 (fr) |
| EP (1) | EP1458704A1 (fr) |
| JP (1) | JP2005518395A (fr) |
| CN (1) | CN1606552A (fr) |
| AU (1) | AU2002351747B2 (fr) |
| CA (1) | CA2467337A1 (fr) |
| HU (1) | HUP0402319A2 (fr) |
| IL (1) | IL162308A0 (fr) |
| MX (1) | MXPA04006119A (fr) |
| NO (1) | NO20043124L (fr) |
| NZ (1) | NZ533217A (fr) |
| WO (1) | WO2003055873A1 (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2467337A1 (fr) * | 2001-12-21 | 2003-07-10 | H. Lundbeck A/S | Derives aminoindane utilises comme inhibiteurs de la capture de la serotonine et de la norepinephrine |
| WO2004087156A1 (fr) | 2003-04-04 | 2004-10-14 | H. Lundbeck A/S | Derives 4-(2-phenylsulfanyl-phenyl)-piperidines utilises en tant qu'inhibiteurs de reabsorption de la serotonine |
| PL1701940T3 (pl) | 2003-12-23 | 2008-11-28 | H Lundbeck As | Pochodne 2-(1H-indolilosulfanylo)benzyloaminy jako SSRI |
| DE102004023635A1 (de) * | 2004-05-10 | 2006-04-13 | Grünenthal GmbH | Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate |
| DE102004023506A1 (de) * | 2004-05-10 | 2005-12-01 | Grünenthal GmbH | Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate |
| DE102004023501A1 (de) * | 2004-05-10 | 2005-12-01 | Grünenthal GmbH | Oxosubstituierte Cyclohexyl-1,4-diamin-Derivate |
| DE102004023507A1 (de) * | 2004-05-10 | 2005-12-01 | Grünenthal GmbH | Substituierte Cyclohexylessigsäure-Derivate |
| DE102004023632A1 (de) * | 2004-05-10 | 2005-12-08 | Grünenthal GmbH | Substituierte Cyclohexylcarbonsäure-Derivate |
| DE102004023522A1 (de) * | 2004-05-10 | 2005-12-01 | Grünenthal GmbH | Substituierte Cyclohexyl-1,4-diamin-Derivate |
| DE102004023508A1 (de) * | 2004-05-10 | 2005-12-08 | Grünenthal GmbH | Säurederivate substituierter Cyclohexyl-1,4-diamine |
| US7396852B2 (en) * | 2005-11-16 | 2008-07-08 | Xerox Corporation | Compound having indolocarbazole moiety and divalent linkage |
| AR052308A1 (es) | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
| CN101300006B (zh) * | 2005-06-02 | 2012-07-25 | 叶林发现公司 | 用于治疗肥胖的mao-b抑制剂 |
| US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| AR054393A1 (es) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
| TW200819426A (en) | 2006-08-31 | 2008-05-01 | Lundbeck & Co As H | Novel indane compounds |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8628644D0 (en) * | 1986-12-01 | 1987-01-07 | Lunbeck A S H | Intermediates |
| DK286990D0 (da) | 1990-12-04 | 1990-12-04 | Lundbeck & Co As H | Indanderivater |
| DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
| DE4228201A1 (de) * | 1992-08-25 | 1994-03-03 | Schering Ag | Neue Leukotrien-B¶4¶-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| GB9315600D0 (en) * | 1993-07-28 | 1993-09-08 | Smithkline Beecham Plc | Compounds |
| GB9315566D0 (en) * | 1993-07-28 | 1993-09-08 | Smithkline Beecham Plc | Medicaments |
| DE69535315T2 (de) * | 1994-01-10 | 2007-06-28 | Teva Pharmaceutical Industries Ltd. | 1-aminoindanderivate und zusammensetzungen hiervon |
| GB9408577D0 (en) | 1994-04-29 | 1994-06-22 | Fujisawa Pharmaceutical Co | New compound |
| US5521213A (en) | 1994-08-29 | 1996-05-28 | Merck Frosst Canada, Inc. | Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| AU8031598A (en) * | 1997-06-05 | 1998-12-21 | Venantius Limited | 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them |
| WO1999035119A1 (fr) * | 1998-01-09 | 1999-07-15 | Pharm-Eco Laboratories, Inc. | Synthese de 3-aryle-1-indanamines |
| BR0012984A (pt) | 1999-08-04 | 2002-07-16 | Millennium Pharm Inc | Método para tratar um estado associado com o mc4-r em um mamìfero, composto de ligação ao mc4-r, e, composição farmacêutica |
| CA2467337A1 (fr) * | 2001-12-21 | 2003-07-10 | H. Lundbeck A/S | Derives aminoindane utilises comme inhibiteurs de la capture de la serotonine et de la norepinephrine |
| TW200819426A (en) * | 2006-08-31 | 2008-05-01 | Lundbeck & Co As H | Novel indane compounds |
-
2002
- 2002-12-18 CA CA002467337A patent/CA2467337A1/fr not_active Abandoned
- 2002-12-18 CN CNA028256883A patent/CN1606552A/zh not_active Withdrawn
- 2002-12-18 EP EP02787462A patent/EP1458704A1/fr not_active Withdrawn
- 2002-12-18 AU AU2002351747A patent/AU2002351747B2/en not_active Expired - Fee Related
- 2002-12-18 WO PCT/DK2002/000873 patent/WO2003055873A1/fr not_active Ceased
- 2002-12-18 HU HU0402319A patent/HUP0402319A2/hu unknown
- 2002-12-18 US US10/496,730 patent/US7351734B2/en not_active Expired - Fee Related
- 2002-12-18 JP JP2003556403A patent/JP2005518395A/ja not_active Withdrawn
- 2002-12-18 NZ NZ533217A patent/NZ533217A/en unknown
- 2002-12-18 IL IL16230802A patent/IL162308A0/xx unknown
- 2002-12-18 MX MXPA04006119A patent/MXPA04006119A/es not_active Application Discontinuation
-
2004
- 2004-07-21 NO NO20043124A patent/NO20043124L/no unknown
-
2008
- 2008-01-09 US US11/971,444 patent/US20080119547A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003055873A1 (fr) | 2003-07-10 |
| IL162308A0 (en) | 2005-11-20 |
| HUP0402319A2 (hu) | 2005-02-28 |
| US7351734B2 (en) | 2008-04-01 |
| CA2467337A1 (fr) | 2003-07-10 |
| US20080119547A1 (en) | 2008-05-22 |
| EP1458704A1 (fr) | 2004-09-22 |
| MXPA04006119A (es) | 2004-11-01 |
| CN1606552A (zh) | 2005-04-13 |
| AU2002351747B2 (en) | 2008-06-05 |
| JP2005518395A (ja) | 2005-06-23 |
| NZ533217A (en) | 2006-02-24 |
| AU2002351747A1 (en) | 2003-07-15 |
| US20050085530A1 (en) | 2005-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20041628L (no) | Fenyl-piperazindernvater som serotonin-reopptaksinhibitorer | |
| NO20034307D0 (no) | Cyklopropylindol-derivater som selektive serotonin- gjenopptaksinhibitorer | |
| NO20033618D0 (no) | Ftalayinon-piperidino-derivater som PDE-4-inhibitorer | |
| NO20030867D0 (no) | Hydroksamderivater anvendelig som deacetylaseinhibitorer | |
| NO20016406D0 (no) | Höyselektive norepinefrin-reopptaksinhibitorer | |
| NO20031450D0 (no) | Fumarsyrederivater som NF-kappa B inhibitorer | |
| NO20044654L (no) | Piperidinoylpiperidiner som 5-HTIF-agonister | |
| NO20044444L (no) | Benzamidderivater nyttige som histondeacetylase inhibitorer | |
| NO20042955L (no) | Substituerte fenylaftalener som estrogene midler | |
| NO20043124L (no) | Aminoindanderivater som serotonin -og norepinefrin-opptaksinhibitorer | |
| DK1638933T3 (da) | N-pyrrolidin-3-yl-amid-derivater som serotonin- og noradrenalin-genoptagelses inhibitorer | |
| NO20050665L (no) | Pyrrolidonderivater som MAOE inhibitoere | |
| NO20042719L (no) | Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer | |
| NO20030842L (no) | Fenoksybenzylaminderivater som selektive serotonin- gjenopptaksinhibitorer | |
| NO20042938L (no) | Nitrogenholdige forbindelser som korrosjonsinhibitorer | |
| DK1438289T3 (da) | Indolderivater som cox II-inhibitorer | |
| NO20040996L (no) | Nye forbindelser og sammensetninger som catepsin-inhibitorer | |
| NO20035328D0 (no) | Nye forbindelser og preparater som katepsinhibitorer | |
| NO20034525D0 (no) | Fenyl heterocyklyleterderivater som serotonin re- opptaksinhibitorer | |
| FI20031191L (fi) | Monoamiinin takaisinoton estäjä | |
| IS7282A (is) | Amínóindan afleiður sem serótónín og noradrenalínupptökuhindrar | |
| DK1377550T3 (da) | Phenyl-heterocyclyletherderivater som serotonin-re-uptakeinhibitorer |